Eisai Oncology Medical
Pharmaceutical Manufacturing
Driven to pursue innovative solutions to help address cancers with unmet needs.
About us
At Eisai Oncology Global Medical Affairs, we are driven to pursue innovative solutions to help address cancers with unmet needs. human health care (hhc) is our goal. At Eisai, everything we do is guided by a simple principle: patients and their families come first, and we have a responsibility to listen to and learn from them. We call this human health care or hhc. During these unprecedented times, our hhc mission is as important as ever. At Eisai, we recognize the mental and physical challenges cancer patients and their loved ones face each day. Therefore, it is our responsibility to share our research and development programs through online channels, so that health care professionals, researchers, and scientists have up-to-date information and access. Community Guidelines: https://www.eisaioncologymedical.com/community-guidelines
- Website
-
https://www.eisai.com/
External link for Eisai Oncology Medical
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,001 employees
- Type
- Public Company
- Founded
- 1941
- Specialties
- Oncology
Employees at Eisai Oncology Medical
-
Ron McDaniel
Federal Sales Specialist - Oncology
-
Jim Greco, PharmD, RPh
Associate Director, Medical Science Liaisons - East Region - Eisai Oncology Medical
-
Keith Savage M.S.
Senior Area Business Leader (District Manager/Key Account Manager) Fort Worth, Dallas, Austin & San Antonio at Eisai US.
-
VINCENZA PAPARELLA
MSL Manager presso Eisai Oncology Medical
Updates
-
The health gaps in uterine cancer are among the largest racial disparities observed for any cancer in the US. Black women are much more likely to develop an aggressive form, called non-endometrioid uterine cancer, and are twice as likely to die from uterine cancer as White women. See our latest research in gynecological cancers: https://ow.ly/RWU750Tniln #GYNCSM
-
DYK: About 41,630 new cases of liver cancer will be diagnosed in the US in 2024, and deaths from this form of cancer have more than doubled since 1980. At Eisai, we’re committed to making advancements in liver cancer research and we have information and resources for those in your care that may help: https://ow.ly/omzl50Tni9V #livercancer #oncology
-
Eisai Oncology Medical reposted this
Cancer clinical trials allow researchers to discover crucial advancements in treatments, ultimately improving outcomes for patients. Watch this video from our partners at CancerCare, to learn more about the value of clinical trials: https://bit.ly/3XEA15p
-
As of 2023, #kidneycancer is among the 10 most common cancers in both men and women. Kidney cancer occurrence rarely shows distinct early signs or symptoms, so we will be sharing some facts for you to know. Do you have any other interesting facts to share? Leave them below! #kidneycancer #RCC
-
The prognosis for patients with advanced RCC is poor, with a 5-year survival rate of 17.4% in the US. Driven by our human health care mission, we focus on addressing urgent, unmet medical needs, and improving the lives of our patients in the US. Learn more here: https://ow.ly/F8xK50TnhMb #kcsm #KidneyCancer
-
The death rate of Black women who are affected by uterine cancer is about double that of White women, reflecting the largest Black-White disparity in 5-year relative survival of all cancers. Let's raise awareness of health disparities in hope of improving early-stage diagnosis trends, leading to greater possibility of successful treatment. Explore our commitment in gynecological cancers: https://ow.ly/WoI850Tnhb2 #GYNCSM
-
For advanced endometrial cancer (EC) patients whose disease has recurred or progressed, the goal of treatment is palliative rather than curative. #ChallengeAccepted #GYNCSM